CDH5 and neoplasm: Although genetically engineered models are used in preclinical studies, the long latency of tumour formation in the Cdh5-CreERT2, Trp53fl/fl mice (median lifespan 325 days) and the development of multiple tumours would make therapeutic efficacy studies costly and challenging.